Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.19.1
Consolidated Statements of Comprehensive Loss - CAD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Profit or loss [Abstract]      
Revenue $ 777,302 $ 109,173  
Cost of revenue 575,172 63,950  
Gross profit 202,130 45,223  
Operating expenses      
Amortization (Note 6) 278,621 124,134 $ 22,567
General and administrative expenses (Note 14) 5,490,938 2,373,251 1,205,835
Research and development expenses (Note 15) 5,566,036 4,430,386 2,778,295
Sales and marketing expenses (Note 16) 1,386,901 631,381 209,455
Stock-based compensation expense (Note 12) 3,228,508 889,511 1,461,189
Share-based payment expense (Note 13) 1,109,531 1,085,716 3,264,681
Operating expenses (17,060,535) (9,534,379) (8,942,022)
Loss before other items (16,858,405) (9,489,156) (8,942,022)
Other items      
Accretion interest expense   69,562 25,908
Changes in fair value of warrant derivative (Note 11) (7,707,051) 186,269  
Finder's fee on convertible loan   258,542  
Impairment of goodwill (Note 7)   1,342,794  
Issue costs allocated to derivative liability (Note 11) 1,493,554    
Foreign exchange loss (gain) (605,096) 20,049 5,417
Loss before taxes (10,039,812) (11,366,372) (8,973,347)
Income tax recovery (1,667)    
Net loss (10,038,145) (11,366,372) (8,973,347)
Other comprehensive loss - foreign currency translation (10,005)    
Comprehensive Loss $ (10,048,150) $ (11,366,372) $ (8,973,347)
Loss per share - basic and fully diluted (in dollars per share) $ (0.38) $ (0.52) $ (0.55)
Weighted average number of shares outstanding - basic and fully diluted (in shares) (Note 12) 26,582,664 21,818,315 16,342,434